Friedrich Karlheinz, Janssen Ottmar, Hass Ralf
Institute of Biochemistry, Friedrich-Schiller University, Jena, Germany.
Sci STKE. 2007 Apr 10;2007(381):pe13. doi: 10.1126/stke.3812007pe13.
On the occasion of the 10th Joint Meeting "Signal Transduction-Receptors, Mediators and Genes" in November 2006, the Signal Transduction Society (STS) focused on the holy grail of translational research, that is, how basic signaling research might be transferred into cancer therapy. Participants heard of blockbusters and setbacks and learned of new therapeutic approaches that concentrate on distinct signaling pathways at a more individual level. Thus, the young STS community and the 300 meeting participants left with an optimistic outlook and the notion that the translational task will keep scientists busy all over the world for a while.
在2006年11月召开的第十届“信号转导——受体、介质与基因”联合会议之际，信号转导学会（STS）聚焦于转化研究的圣杯，即基础信号研究如何转化为癌症治疗。与会者听闻了重大成果与挫折，并了解到更具个体化层面、专注于不同信号通路的新治疗方法。因此，年轻的STS群体以及300名与会者带着乐观的展望和这样一种观念离开：转化任务将使世界各地的科学家们在一段时间内忙碌不停。
